News Conference News VIVA 2024 It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now? L.A. McKeown November 14, 2024
News Conference News VIVA 2024 DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years L.A. McKeown November 11, 2024
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
News Conference News ISET 2020 Venous Stents: Long-term Follow-up Plus a New Contender Caitlin E. Cox January 24, 2020
News Conference News VIVA 2019 Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee? L.A. McKeown November 06, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Conference News ISET 2019 Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS Caitlin E. Cox February 08, 2019
News Conference News ISET 2019 Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis Caitlin E. Cox January 30, 2019
News Conference News VIVA 2018 VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease L.A. McKeown November 08, 2018
News Conference News VIVA 2018 IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions L.A. McKeown November 06, 2018
News Conference News TCT 2018 Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released Todd Neale September 24, 2018
News Conference News TCT 2018 IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease Todd Neale September 22, 2018
News Conference News ISET 2018 WISE LE Data Build the Case for Embolic Protection in Lower-Extremity Atherectomy Caitlin E. Cox February 13, 2018
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Conference News ISET 2017 Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study Caitlin E. Cox February 10, 2017
News Conference News VIVA 2016 Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear L.A. McKeown September 21, 2016